384 related articles for article (PubMed ID: 15830061)
1. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
Cardoso E; Rodrigues B; Lucena R; Oliveira IR; Pedreira G; Melo A
Arq Neuropsiquiatr; 2005 Mar; 63(1):30-3. PubMed ID: 15830061
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
Buyukavci R; Akturk S; Ersoy Y
Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
[TBL] [Abstract][Full Text] [Related]
3. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
Olvey EL; Armstrong EP; Grizzle AJ
Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity.
Rosales RL; Chua-Yap AS
J Neural Transm (Vienna); 2008; 115(4):617-23. PubMed ID: 18322637
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A for upper limb spasticity after stroke.
Shaw L; Rodgers H
Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
Do KH; Chun MH; Paik NJ; Park YG; Lee SU; Kim MW; Kim DK
Clin Rehabil; 2017 Sep; 31(9):1179-1188. PubMed ID: 28118733
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study.
Datta Gupta A; Visvanathan R; Cameron I; Koblar SA; Howell S; Wilson D
BMC Neurol; 2019 May; 19(1):96. PubMed ID: 31078139
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
[TBL] [Abstract][Full Text] [Related]
11. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
Seo HG; Paik NJ; Lee SU; Oh BM; Chun MH; Kwon BS; Bang MS
PLoS One; 2015; 10(6):e0128633. PubMed ID: 26030192
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Extracorporeal Shock Wave Therapy after Botulinum Toxin Injection for Post-Stroke Upper Extremity Spasticity: A Randomized Controlled Study.
Lee J; Yang SN
Toxins (Basel); 2024 Apr; 16(4):. PubMed ID: 38668622
[TBL] [Abstract][Full Text] [Related]
13. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials.
Jia S; Liu Y; Shen L; Liang X; Xu X; Wei Y
J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104682. PubMed ID: 32305277
[TBL] [Abstract][Full Text] [Related]
14. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
Dong Y; Wu T; Hu X; Wang T
Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
Sheean G
Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
[TBL] [Abstract][Full Text] [Related]
17. Treatment with botulinum toxin improves upper-extremity function post stroke: a systematic review and meta-analysis.
Foley N; Pereira S; Salter K; Fernandez MM; Speechley M; Sequeira K; Miller T; Teasell R
Arch Phys Med Rehabil; 2013 May; 94(5):977-89. PubMed ID: 23262381
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
Lee J; Chun MH; Ko YJ; Lee SU; Kim DY; Paik NJ; Kwon BS; Park YG
Arch Phys Med Rehabil; 2020 Sep; 101(9):1485-1496. PubMed ID: 32497599
[TBL] [Abstract][Full Text] [Related]
19. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb.
Lagalla G; Danni M; Reiter F; Ceravolo MG; Provinciali L
Am J Phys Med Rehabil; 2000; 79(4):377-84; quiz 391-4. PubMed ID: 10892624
[TBL] [Abstract][Full Text] [Related]
20. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
Marciniak CM; Harvey RL; Gagnon CM; Duraski SA; Denby FA; McCarty S; Bravi LA; Polo KM; Fierstein KM
Am J Phys Med Rehabil; 2012 Dec; 91(12):1007-19. PubMed ID: 23064478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
